(GILD) Gilead Sciences - Performance 53.2% in 12m
GILD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
67.70%
#5 in Peer-Group
Rel. Strength
87.30%
#979 in Stock-Universe
Total Return 12m
53.22%
#22 in Peer-Group
Total Return 5y
70.22%
#16 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 24.1 |
| P/E Forward | 14.3 |
| High / Low | USD |
|---|---|
| 52 Week High | 115.77 USD |
| 52 Week Low | 68.95 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 25.94 |
| Buy/Sell Signal +-5 | -0.47 |
| Support / Resistance | Levels |
|---|---|
| Support | 108.8, 105.5, 103.1, 88.6, 86.7, 85.3 |
| Resistance |
12m Total Return: GILD (53.2%) vs XBI (-11.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.74% | 53.2% | 70.2% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.64% | -10.3% | 158% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.83% | -8.28% | 33.6% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
7.39% | -7.29% | 0.13% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-1% | 26.9% | -7.57% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
4.06% | 31.3% | -17.2% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.56% | 41.9% | -8.93% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
- | 27% | 13.6% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: GILD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GILD
| Total Return (including Dividends) | GILD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.74% | 7.34% | 5.42% |
| 3 Months | 4.81% | 16.06% | 19.66% |
| 12 Months | 53.22% | -11.67% | 14.17% |
| 5 Years | 70.22% | -26.49% | 107.98% |
| Trend Stabilty (consistency of price movement) | GILD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 56.2% | 88.2% | 91.9% |
| 3 Months | 79% | 79.7% | 97.6% |
| 12 Months | 91.7% | -86.7% | 47.9% |
| 5 Years | 85% | -51.5% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th31.00 | -6.15% | -4.44% |
| 3 Month | %th31.50 | -9.69% | -12.41% |
| 12 Month | %th89.50 | 73.47% | 34.20% |
| 5 Years | %th94.00 | 131.57% | -18.15% |
FAQs
Does Gilead Sciences (GILD) outperform the market?
Yes,
over the last 12 months GILD made 53.22%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.67%.
Over the last 3 months GILD made 4.81%, while XBI made 16.06%.
Performance Comparison GILD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GILD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.4% | -4.7% | 14.4% | 39% |
| US NASDAQ 100 | QQQ | -6.2% | -5.6% | 12.2% | 36% |
| German DAX 40 | DAX | -4.7% | -3.3% | 4.1% | 22% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.8% | -5.4% | 10.7% | 34% |
| Hongkong Hang Seng | HSI | -6.6% | -3.8% | -6.1% | 18% |
| India NIFTY 50 | INDA | -4.5% | -1.5% | 12.7% | 56% |
| Brasil Bovespa | EWZ | -4.9% | 2.2% | 0.4% | 51% |
GILD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -5% | -2.7% | 10% | 27% |
| Consumer Discretionary | XLY | -4.5% | -4.2% | 23.6% | 37% |
| Consumer Staples | XLP | -5% | -0.7% | 13.9% | 48% |
| Energy | XLE | -2.7% | 2.2% | 26.4% | 57% |
| Financial | XLF | -4.6% | -4.1% | 14.9% | 32% |
| Health Care | XLV | -2.4% | 0.8% | 24.7% | 64% |
| Industrial | XLI | -5.7% | -6.1% | 9.3% | 32% |
| Materials | XLB | -2.6% | -2.9% | 17.2% | 53% |
| Real Estate | XLRE | -5.3% | -0.1% | 17% | 48% |
| Technology | XLK | -6.6% | -7.6% | 8.3% | 36% |
| Utilities | XLU | -4.8% | -2.5% | 14.2% | 32% |
| Aerospace & Defense | XAR | -11.3% | -12.1% | -9.2% | 1% |
| Biotech | XBI | -4.7% | -6.6% | 20% | 65% |
| Homebuilder | XHB | -1.6% | -9.4% | 27.2% | 61% |
| Retail | XRT | -3.2% | -3.8% | 18.3% | 50% |
GILD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -6% | 8.20% | 27.9% | 59% |
| Natural Gas | UNG | -11.5% | 11.4% | 34.5% | 39% |
| Gold | GLD | -5.5% | 2.1% | -3.3% | 18% |
| Silver | SLV | -7.7% | -2% | -5.4% | 28% |
| Copper | CPER | -3.1% | -13.3% | -5.2% | 29% |
GILD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.9% | 2% | 20.4% | 59% |
| iShares High Yield Corp. Bond | HYG | -5% | -0.6% | 16.4% | 45% |